Can you talk about the exploration and practice of Yuekang Pharmaceutical in the field of biomedicine?

Yuekang Pharmaceutical has made phased progress in the development of biomedicine in recent years. The platform for research, development and pilot production of small nucleic acid drugs and mRNA vaccines has been built, which strengthens the whole chain research and development capability from target screening and confirmation, sequence design, antigen design, efficacy evaluation, CMC pilot and pilot, clinical trials to registration and declaration.